Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin ® with a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology

ConclusionBesides having an overall high analytical similarity to both EU-Herceptin® and CN-Herceptin®, HLX02 is more similar to Herceptin® with high Fc γRIIIa affinity, a result that demonstrates the power of the novel FcγRIIIa affinity chromatography technology in biosimilarity evaluation.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research